Decreasing Costs for the Geenius HIV 1/2 Supplemental Assay
TCPH’s NTRL took a Plan, Do, Study, Act (PDSA) approach to identify and test cost-saving measures for a new HIV test it had begun to use. The team pilot-tested an individual quality control plan (IQCP) for the Geenius HIV 1/2 Supplemental Assay that enabled the laboratory to move from day-of-use control testing to monthly control testing for this particular assay. The Geenius assay is a high-cost, low-demand test, and because it is needed for rapid diagnosis and treatment of HIV infection, it is not possible to batch these tests and thus decrease the number of times the test itself is performed. An alternative, monthly control test was deemed to be the best option for providing cost reductions. The team cut the cost of the test by 40% by decreasing the number of times control testing is performed.
Turnage, N. Public Health Quality Improvement Exchange. Decreasing Costs for the Geenius HIV 1/2 Supplemental Assay. Tue, 04/03/2018 - 16:59. Available at http://phqix.org/content/decreasing-costs-geenius-hiv-12-supplemental-assay. Accessed December 3, 2020.
Background and Aim
Planning and Execution Details